Breaking Finance News

Cardinal Health Inc. (NYSE:CAH) target price raised to $72.00, reported today by RBC Capital Markets

Just yesterday Cardinal Health Inc. (NYSE:CAH) traded -1.33% lower at $66.15. Cardinal Health Inc.’s 50-day moving average is $68.00 and its 200-day moving average is $74.84. The last stock price is down -11.57% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the same time period. 1,266,339 shares of CAH traded hands, down from an average trading volume of 2,137,250

Cardinal Health Inc. (NYSE:CAH) had its target price raised to $72.00 by RBC Capital Markets in a report released 9/19/2017. The new target price indicates a possible upside of 0.09% based on the company's previous stock price.

Recent Performance Chart

Cardinal Health Inc. (NYSE:CAH)

Cardinal Health Inc. has 52 week low of $62.70 and a 52 week high of $84.88 with a PE ratio of 16.42 and has a market capitalization of $0.

In addition to RBC Capital Markets reporting its stock price target, a total of 15 brokerages have issued a ratings update on the company. The average stock price target is $91.93 with 7 brokerages rating the stock a strong buy, 5 brokerages rating the stock a buy, 7 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Cardinal Health Inc. (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.